AUTHOR=Wu Jinchun , Liu Yanmin , Wei Xiaojuan , Zhang Xiaofei , Ye Yi , Li Wei , Su Xiaoling TITLE=Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: A mini review JOURNAL=Frontiers in Cardiovascular Medicine VOLUME=9 YEAR=2022 URL=https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.915455 DOI=10.3389/fcvm.2022.915455 ISSN=2297-055X ABSTRACT=

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a new type of oral hypoglycaemic agent with good cardiovascular protective effects. There are several lines of clinical evidence suggest that SGLT2i can significantly reduce the risks of heart failure, cardiovascular death, and delay the progression of chronic kidney disease. In addition, recent basic and clinical studies have also reported that SGLT2i also has good anti-arrhythmic effects. However, the exact mechanism is poorly understood. The aim of this review is to summarize recent clinical findings, studies of laboratory animals, and related study about this aspect of the antiarrhythmic effects of SGLT2i, to further explore its underlying mechanisms, safety, and prospects for clinical applications of it.